Grant Awardees March-April 2015

Thursday, May 07, 2015

 

Congratulations to Carver College of Medicine Grant Awardees from March-April 2015!

NameDepartmentSponsorProposal Title
Abel, E. DaleInternal MedicineUS Department of Health & Human Services, National Institutes of HealthInsulin Inhibition of betaAR signaling in the myocardium
Ahrens, RichardPediatricsN30 Pharmaceuticals, Inc.A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients with Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Ahrens, RichardPediatricsSeattle Children's Research InstituteEarly Intervention in Cystic Fibrosis Exacerbation (eICE)
Anderson, MichaelMolecular Physiology & BiophysicsUS Department of Veterans AffairsTherapy of Nocturnal Intraocular Pressure Elevation Causing Glaucoma Progression
Bender, DavidObstetrics & GynecologySociety of Gynecologic OncologySGO Cervical Outcomes Registry
Berg, DanielInternal MedicineMillennium Pharmaceuticals, Inc.A Phase 2 Trial of MLN0264 in Previously Treated Patients With Advanced or Metastatic Pancreatic Adenocarcinoma Expressing Guanylyl Cyclase C (GCC)
Boyden, AlexanderPathologyNational Multiple Sclerosis SocietyThe role of CD8+ regulatory T cells in modulating B cell function during EAE
Brennan, TimothyAnesthesiaConcentric Analgesics, Inc.Effect of CA-008 infiltration on Acute Pain from Incision
Brophy, PatrickPediatricsAmgen, Inc.Amgen Study 20130356
Brophy, PatrickPediatricsSeattle Children's Research InstituteRecombinant Erythropoientin Protects Against Chronic Kidney Disease
Comellas, AlejandroInternal MedicineAstraZeneca Pharmaceuticals LPA 12-week Phase IIa, Double-blind, Placebo-controlled, Randomized Study
Cullen, JosephSurgeryUS Department of Health & Human Services, National Institutes of HealthPharmacological Ascorbate as a Radiosensitizer in Pancreatic Cancer
Ellermeier, CraigMicrobiologyEntera Health, Inc.Entera Health
Engelhardt, JohnAnatomy & Cell BiologyUS Department of Health & Human Services, National Institutes of HealthCenter for Gene Therapy of Cystic Fibrosis
Ford, BradleyPathologyAccelerate Diagnostics, Inc.Accelerate Clinical Trial Clinical Lab Model
Ford, BradleyPathologyCepheidCepheid Clinical Study
Giudici, MichaelInternal MedicineCardionomic, Inc.Cardiac Autonomic Nerve Activation to Increase Contractility
Giudici, MichaelInternal MedicineMedtronic, Inc.VICTORY AF trial
Grobe, JustinPharmacologyAmerican Diabetes AssociationRequired Interaction of Leptin with Angiotensin in Metabolic Control
Hansen, MarlanOtolaryngology - Head & Neck SurgeryAuris MedicalEfficacy and Safety of AM-101 in the Treatment of Acute Peripheral Tinnitus 2 (TACTT2)
Hodgson-Zingman, DeniceInternal MedicineSt. Jude Medical, Inc.EP Fellowship Grant 2015-16 academic year
Hoffman, EricRadiologyUS Department of Health & Human Services, National Institutes of HealthDefining the role of early pulmonary vascular disease in COPD
Hoffman, EricRadiologyUS Department of Health & Human Services, National Institutes of HealthSPIROMICS-Radiology Center
Horwitz, PhillipInternal MedicineEdwards Lifesciences LLCPARTNER 2 Sapien 3i Continued Access Protocol (CAP)
Horwitz, PhillipInternal MedicineSt. Jude Medical, Inc.Interventional Cardiology Fellowship Grant 2015-16 academic year
Ince, DilekInternal MedicineChimerix, Inc.A Phase 3, Open-label, Multicenter Study of the Safety/Tolerability and Efficacy of Brincidofovir (CMX001) for the Prevention of Adenovirus (AdV) Disease in Subjects with Asymptomatic AdV Infection at Risk of Progression and for the Treatment of Subjects
Joshi, CharutaPediatricsGW PharmaceuticalsJOSHI- GW Pharmaceuticals - GWEP1423
Joshi, CharutaPediatricsGW PharmaceuticalsJOSHI - GW Pharmaceuticals - An open label extension study to investigate the safety of cannabidiol (GWP42003-P; CBD) in children and adults with inadequately controlled Dravet or Lennox-Gastaut Syndromes
Kline, JoelInternal MedicineAmgen, Inc.A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and
Light-McGroary, KellyAnnInternal MedicineRiboCor, Inc.A Randomized, Double-Blind, Placebo-controlled Study To Evaluate D-Ribose For The Treatment Of Congestive Heart Failure
Lim, Tiffany Yue-FaiMicrobiologyUS Department of Health & Human Services, National Institutes of HealthThe Role of Inflammasomes in Bacterial Co-Infection during Cutaneous Leishmaniasis
Lindgren, ScottPediatricsUS Department of Health & Human Services, National Institutes of HealthComparing Behavioral Asssessments Using Telehealth for Children with Autism
Link, BrianInternal MedicineKite Pharma, Inc.Outcomes in Relapsed and Refractory Diffuse Large B-Cell Lymphoma: Analysis of the University of Iowa/Mayo Clinic Molecular Epidemiology Resource
Mahajan, VinitOphthalmology & Visual SciencesUS Department of Health & Human Services, National Institutes of HealthMechanism-based Therapies for Photoreceptor Degeneration
Mahajan, VinitOphthalmology & Visual SciencesUS Department of Health & Human Services, National Institutes of HealthEvaluating GWAS AMD Candidate Loci by Gene Editing in Human iPS Cells
Mangalam, AshutoshPathologyNational Multiple Sclerosis SocietyTherapeutic potential of combination therapy using Human Gut-derived commensal bacteria and conventional MS drugs
Mathews, KatherinePediatricsSarepta TherapeuticsSarepta 203
Mathews, KatherinePediatricsSarepta TherapeuticsSarepta 204
Mathews, KatherinePediatricsPfizer, Inc.Pfizer 210966/B5161002 Study
Milhem, MohammedInternal MedicineMayo ClinicA Randomized Phase II Study of Sequential Biotherapy with Aflibercept and High Dose IL-2 versus High Dose IL-2 alone in Patients with Inoperable Stage III or Stage IV Melanoma: Efficacy and Biomarker Study.
Milhem, MohammedInternal MedicineNewLink Genetics CorporationA Phase IIB Study of Ipilimumab with or without HyperAcute-Melanoma Immunotherapy for Stage IV Melanoma Patients
Milhem, MohammedInternal MedicineJanssen Research & Development, Inc.A randomized controlled study of YONDELIS (Trabectedin) or Dacarbazine for the treatment of advanced liposarcoma or Leiomyosarcoma previously treated with Anthracycline and Ifosfamide
Milhem, MohammedInternal MedicineNorthwestern UniversityNU 13S02 Multicenter, Open-Label Phase II Study of Daily Oral Regorafenib for
Miller, DelwynPsychiatryOtsuka Pharmaceutical Company, Ltd.PRELAPSE - A Cluster Randomized, Multi-center, Parallel-group, Rater-blind Study Comparing Treatment with Aripiprazole Once Monthly and Treatment as Usual on Effectiveness in First Episode and Early Phase Illness in Schizophrenia
Nugent, AndrewProgram in Emergency MedicineEPIC Research and Diagnostics, Inc.EPIC Traumatic Brain Injury Feasibility Study
Paulsen, JanePsychiatryUniversity of California, IrvineCSF-Enhanced-Aggregation Biomarker to Monitor Huntington's Disease Progression
Paulsen, JanePsychiatryUniversity of MichiganValidation of the HD-HRQoL (Huntington Disease Quality of Life Measure)
Paulsen, JanePsychiatryAuspex Pharmaceuticals, Inc.An Open-Label, Long Term Safety Study of SD-809 ER in Patients with Chorea Associated with Huntington Disease (ARC-HD)
Philibert, RobertPsychiatryUniversity of GeorgiaVulnerability to Drug Use and HIV: Advancing Prevention for Rural African Americans
Pieper, AndrewPsychiatryCalicoCalico / Pieper Laboratory
Polyak, StevenInternal MedicineAbbVie Inc.A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA (Adalimumab) in Patients with Moderately to Severely Active Ulcerative Colitis
Polyak, StevenInternal MedicineUniversity of MichiganA Randomized Controlled Trial of High Dose Vitamin D Therapy in Crohn's Disease
Price, NathanPediatricsDuke UniversityA Phase 1, Open-label, Multi-center Study to Determine the Pharmacokinetics and Safety of Solithromycin as Add-on Therapy in Adolescents and Children with Suspected or Confirmed Bacterial Infection
Randak, ChristophPediatricsCystic Fibrosis FoundationPotentiating F508 CRTR Channel Function with an Adenylate Kinase Inhhibitor
Rosenthal, GaryInternal MedicineUniversity of Kansas Medical Center Research Institute, Inc.Greater Plains Collaborative Clinical Data Research Network
Roy, RupaliInternal MedicinePharmacyclics, Inc.A Multicenter Open-Label Phase 2a Study of Ibrutinib With or
Sabharwal, RasnapreetInternal MedicineTarix Pharmaceuticals LimitedNeurohumoral Actions of Angiotensin-(1-7) Analogs in Limb Girdle MD and ALS
Samuel, IsaacSurgeryFoundation for Surgical FellowshipsFellowship in Bariatric Surgery
Schartz, KevinRadiologyUS Department of Health & Human Services, National Institutes of HealthModern ROC Software for Multi- and Single-Reader Diagnostic Imaging Studies
Schartz, KevinRadiologyUniversity of California, Santa BarbaraUtility-Based Assessment of Diagnostic Imaging Performance
Schultz, MichaelRadiologyUniversity of Texas Health Science Center at HoustonDevelopment of Hybrid Somatostatin Analogs for Surgical Guidance
Schultz, SusanPsychiatryUniversity of California, San DiegoAnti-Amyloid Treatment in Asymptomatic Alzheimer's Disease - Tau (A4-Tau) Addendum
Segar, JeffreyPediatricsInfaCare Pharmaceutical CorporationA 48-52 Month Blinded-Outcomes Follow Up Study of Patients Having Received Stannsoporfin or Placebo in Clinical Trial 64,185-205
Serrano Russi, AlvaroPediatricsArkansas Children's Hospital Research InstituteIBEM-IS Data Entry Project
Sigmund, CurtPharmacologyAmerican Heart AssociationUniversity of Iowa Strategically Focused Hypertension Research Center
Stapleton, JackInternal MedicineBavarian NordicBN-POX-MVA-037
Stapleton, JackInternal MedicineUS Department of Veterans AffairsThe effects of Hepatitis C Virus (HCV) E2 protein on host immunomodulation
Stevens, HannaPsychiatryRobert Leet & Clara Guthrie Patterson TrustDevelopmental Psychopathology and Prenatal Stress Mechanisms and Prevention of Risk
Stevens, HannaPsychiatryYale UniversityBehavioral Epidemiology of Intensive In-Home Child and Adolescent Psychiatric Services
Stone, EdwinOphthalmology & Visual SciencesFoundation Fighting BlindnessFFB-MAK-Associated RP Research Fund
Taylor, EricBiochemistryUS Department of Health & Human Services, National Institutes of HealthRegulation of Hepatic Gluconeogenesis by the Mitochondrial Pyruvate Carrier
Tricot, GuidoInternal MedicineNovartis Pharmaceuticals CorporationExploit whether LBH589 can deplete the myeloma drug-resistant fraction
Turvey, CarolynPsychiatryBaylor College of MedicineOne-Day Intervention for Depression and Impairment in Migraine Patients
Vaena, DanielInternal MedicineBristol-Myers Squibb CompanyA Phase II Single Arm Clinical Trial of Nivolumab (BMS-936558) in Subjects with Metastatic or Unresectable Urothelial Cancer who have Progressed or Recurred Following Treatment with a Platinum Agent
Vaena, DanielInternal MedicineTRACON Pharmaceuticals, Inc.A Randomized Phase 2 Trial of Axitinib and TRC105 Versus Axitinib Alone (Including a Lead-In Phase 1B Dose-Escalation Portion) in Patients with Advanced or Metastatic Renal Cell Carcinoma
Vaena, DanielInternal MedicineAstraZeneca Pharmaceuticals LPA Phase II Trial to Evaluate the Efficacy of AZD6094 (HMPL-504) in Patients with Papillary Renal Cell Carcinoma (PRCC)
Weigel, RonaldSurgeryUS Department of Health & Human Services, National Institutes of HealthRET as a Novel Therapeutic Target for Breast Cancer
Weiner, GeorgeCancer CenterUS Department of Health & Human Services, National Institutes of HealthCancer Center Support Grant - (CCSG)
Weiss, DavidMicrobiologyUS National Science FoundationREU Site: Microbiology at The University of Iowa
Wibbenmeyer, LucySurgeryQueen's University, Kingston General Hospital, Ontario, CanadaA Randomized Trials of the Enteral Glutamine to Minimize Thermal Injury
Xue, Hai-HuiMicrobiologyUS Department of Health & Human Services, National Institutes of HealthTcf/Lef-b-catenin in T cell identity and cancer
Zavazava, NicholasInternal MedicineReproCELL Inc.3D Differentiation of human-induced pluripotent stem cells into insuling-producing cells using a bioactive ECM scaffold
Date: 
Thursday, May 7, 2015